Published in Circulation on January 01, 1991
Impact of the control of symptomatic paroxysmal atrial fibrillation on health-related quality of life. Europace (2010) 2.12
State-dependent trapping of flecainide in the cardiac sodium channel. J Physiol (2004) 1.13
Flecainide acetate for long-term prevention of paroxysmal supraventricular tachyarrhythmias. Circulation (1991) 0.83
Comparison of the effects of antiarrhythmic drugs flecainide and verapamil on fKv1.4ΔN channel currents in Xenopus oocytes. Acta Pharmacol Sin (2012) 0.75
Health care utilization among adenosine-sensitive supraventricular tachycardia patients presenting to the emergency department. J Interv Card Electrophysiol (2017) 0.75
A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med (2002) 16.31
Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med (1996) 15.04
The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N Engl J Med (1996) 12.77
Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 genotypes and warfarin dosing. Clin Pharmacol Ther (2011) 4.42
Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators. Circulation (1996) 4.01
Race and the response to adrenergic blockade with carvedilol in patients with chronic heart failure. N Engl J Med (2001) 3.44
Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group. Lancet (1993) 3.20
Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. US Carvedilol Heart Failure Study Group. Circulation (1996) 3.14
Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomized study. J Am Coll Cardiol (1995) 3.12
Clinical use of the total artificial heart. N Engl J Med (1984) 2.94
A randomized trial of intracoronary streptokinase in the treatment of acute myocardial infarction. N Engl J Med (1983) 2.85
ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol (1996) 2.81
The "on-off" phenomenon in Parkinson's disease. Relation to levodopa absorption and transport. N Engl J Med (1984) 2.71
Inoculum standardization in antimicrobial susceptibility testing: evaluation of overnight agar cultures and the Rapid Inoculum Standardization System. J Clin Microbiol (1983) 2.71
An emergency department-based protocol for rapidly ruling out myocardial ischemia reduces hospital time and expense: results of a randomized study (ROMIO). J Am Coll Cardiol (1996) 2.46
Restricted transport in small pores. A model for steric exclusion and hindered particle motion. Biophys J (1974) 2.42
The long QT syndromes: a critical review, new clinical observations and a unifying hypothesis. Prog Cardiovasc Dis (1988) 2.42
Effects of vesnarinone on morbidity and mortality in patients with heart failure. Vesnarinone Study Group. N Engl J Med (1993) 2.39
Pathophysiology and prevention of atrial fibrillation. Circulation (2001) 2.31
Imaging dispersion of myocardial repolarization, II: noninvasive reconstruction of epicardial measures. Circulation (2001) 2.31
Bone-marrow transplantation in a patient with the Wiskott-Aldrich syndrome. Lancet (1968) 2.29
Changes in gene expression in the intact human heart. Downregulation of alpha-myosin heavy chain in hypertrophied, failing ventricular myocardium. J Clin Invest (1997) 2.29
The preexcitation syndromes. Prog Cardiovasc Dis (1978) 2.23
HLA class II (DR and DQ) antigen associations in idiopathic dilated cardiomyopathy. Validation study and meta-analysis of published HLA association studies. Circulation (1991) 2.22
Integration of genetic, clinical, and INR data to refine warfarin dosing. Clin Pharmacol Ther (2010) 2.21
Ventricular fibrillation in the Wolff-Parkinson-White syndrome. N Engl J Med (1979) 2.20
Time delays in the diagnosis and treatment of acute myocardial infarction: a tale of eight cities. Report from the Pre-hospital Study Group and the Cincinnati Heart Project. Am Heart J (1990) 2.14
Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia. Circulation (1994) 2.10
Mechanism of osmotic flow in porous membranes. Biophys J (1974) 2.07
Physician attitudes about anticoagulation for nonvalvular atrial fibrillation in the elderly. Arch Intern Med (1995) 2.00
Oral flecainide acetate for the treatment of ventricular arrhythmias. N Engl J Med (1981) 1.99
Cytomegalovirus seropositivity and C-reactive protein have independent and combined predictive value for mortality in patients with angiographically demonstrated coronary artery disease. Circulation (2000) 1.92
Standardized full-field electroretinography. Normal values and their variation with age. Arch Ophthalmol (1992) 1.92
Coronary spasm producing coronary thrombosis and myocardial infarction. N Engl J Med (1983) 1.91
Evaluation of the Prompt inoculation system for preparation of standardized bacterial inocula. J Clin Microbiol (1983) 1.88
Idiopathic cardiomyopathy, age, and suppressor-cell dysfunction as risk determinants of lymphoma after cardiac transplantation. Lancet (1978) 1.87
Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model. Circulation (1998) 1.86
Yearly rates of rod and cone functional loss in retinitis pigmentosa and cone-rod dystrophy. Ophthalmology (1999) 1.80
Randomized secondary prevention trial of azithromycin in patients with coronary artery disease: primary clinical results of the ACADEMIC study. Circulation (2000) 1.74
Atrioverter: an implantable device for the treatment of atrial fibrillation. Circulation (1998) 1.74
Angiotensin-converting enzyme gene polymorphism is associated with myocardial infarction but not with development of coronary stenosis. Circulation (1995) 1.73
Implementation of a computerized cardiovascular information system in a private hospital setting. Am Heart J (1998) 1.68
S-cone function in patients with retinitis pigmentosa. Invest Ophthalmol Vis Sci (1993) 1.65
Patient information recall in a rheumatology clinic. Rheumatol Rehabil (1979) 1.62
Prospective study of pathogen burden and risk of myocardial infarction or death. Circulation (2001) 1.61
HLA haplotypes in a family with multiple cases of rheumatoid arthritis. J Rheumatol (1982) 1.59
Torsade de pointes: the long-short initiating sequence and other clinical features: observations in 32 patients. J Am Coll Cardiol (1983) 1.58
Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease. J Am Coll Cardiol (1996) 1.55
Combined oral positive inotropic and beta-blocker therapy for treatment of refractory class IV heart failure. J Am Coll Cardiol (1998) 1.53
Simple inoculum standardizing system for antimicrobial disk susceptibility tests. J Clin Microbiol (1979) 1.52
Effects of carvedilol on systolic and diastolic left ventricular performance in idiopathic dilated cardiomyopathy or ischemic cardiomyopathy. Am J Cardiol (1996) 1.52
Entrainment and interruption of atrial flutter with atrial pacing: studies in man following open heart surgery. Circulation (1977) 1.48
Onset of induced atrial flutter in the canine pericarditis model. J Am Coll Cardiol (1991) 1.48
Coordinate changes in Myosin heavy chain isoform gene expression are selectively associated with alterations in dilated cardiomyopathy phenotype. Mol Med (2002) 1.47
Partitioning and diffusion of proteins and linear polymers in polyacrylamide gels. Biophys J (1996) 1.46
Changes in spontaneous variability of ventricular ectopic activity as a function of time in patients with chronic arrhythmias. Circulation (1988) 1.45
Rationale, design, and methods for a Coreg (carvedilol) Heart Failure Registry (COHERE). COHERE Participant Physicians. J Card Fail (2000) 1.44
Patient preferences and the bedside manner. Med Educ (1982) 1.41
The case for just plain "atrial fibrillation". Pacing Clin Electrophysiol (1998) 1.39
Evaluation of antiarrhythmic drug efficacy in patients with an ICD: unlimited potential or replete with complexity and problems? J Cardiovasc Electrophysiol (1999) 1.39
Influence of inoculum growth phase on microdilution susceptibility tests. J Clin Microbiol (1983) 1.38
Genetics informatics trial (GIFT) of warfarin to prevent deep vein thrombosis (DVT): rationale and study design. Pharmacogenomics J (2011) 1.38
Nuclear preparations of SV40-transformed cells contain tumor-specific transplantation antigen activity. Virology (1977) 1.37
Biobehavioral variables and mortality or cardiac arrest in the Cardiac Arrhythmia Pilot Study (CAPS). Am J Cardiol (1990) 1.35
Treatment of refractory cardiac allograft rejection with OKT3 monoclonal antibody. Am J Med (1987) 1.34
Reduced verapamil clearance during long-term oral administration. Clin Pharmacol Ther (1981) 1.31
Thrombolysis and myocardial salvage. Results of clinical trials and the animal paradigm--paradoxic or predictable? Circulation (1993) 1.28
Reduction in QT interval dispersion by successful thrombolytic therapy in acute myocardial infarction. TEAM-2 Study Investigators. Circulation (1994) 1.26
Characterization of atrial fibrillation in man: studies following open heart surgery. Pacing Clin Electrophysiol (1978) 1.25
Malignant neoplasms following cardiac transplantation. JAMA (1978) 1.24
Intracardiac repair of cardiac malformations with atrioventricular discordance. Circulation (1976) 1.24
Usefulness of in-hospital prescription of statin agents after angiographic diagnosis of coronary artery disease in improving continued compliance and reduced mortality. Am J Cardiol (2001) 1.24
Risk factors for congenital hypothyroidism: an investigation of infant's birth weight, ethnicity, and gender in California, 1990-1998. Teratology (2000) 1.23
Treatment of breast cancer: doctor/patient communication and psychosocial implications. Proc R Soc Med (1975) 1.23
Imaging dispersion of myocardial repolarization, I: comparison of body-surface and epicardial measures. Circulation (2001) 1.22
Simultaneous multisite mapping studies during induced atrial fibrillation in the sterile pericarditis model. Insights into the mechanism of its maintenance. Circulation (1997) 1.21
Model pores of molecular dimension. The preparation and characterization of track-etched membranes. Biophys J (1972) 1.21
Beta-adrenergic pathways in nonfailing and failing human ventricular myocardium. Circulation (1990) 1.21
Kinetics and yield of singlet oxygen photosensitized by hypericin in organic and biological media. Photochem Photobiol (1998) 1.21
Clinical features of Wolff-Parkinson-White syndrome. Am Heart J (1999) 1.21
Statin therapy, lipid levels, C-reactive protein and the survival of patients with angiographically severe coronary artery disease. J Am Coll Cardiol (2000) 1.20
A randomized trial of intravenous and intracoronary streptokinase in patients with acute myocardial infarction. Circulation (1984) 1.19
The spontaneous occurrence of paroxysmal supraventricular tachycardia. Circulation (1984) 1.18
Importance of atrial flutter isthmus in postoperative intra-atrial reentrant tachycardia. Circulation (2000) 1.18
Emotional stressors trigger cardiovascular events. Int J Clin Pract (2012) 1.18
Atrial fibrillation in the preexcitation syndrome. Am J Cardiol (1977) 1.18
Coffee consumption and cause-specific mortality. Association with age at death and compression of mortality. J Clin Epidemiol (1992) 1.17
Expression and thermal stability of simian virus 40 tumor-specific transplantation antigen and tumor antigen in wild type- and tsA mutant-transformed cells. J Virol (1977) 1.15
Neutrophil dysfunction in diabetes mellitus. J Lab Clin Med (1975) 1.15